200,000+ products from a single source!

sales@angenechem.com

Home > Carboxes > 101363-10-4

101363-10-4

101363-10-4 | 7H-Pyrido[1,2,3-de]-1,4-benzothiazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-10-(4-methyl-1-piperazinyl)-7-oxo-

CAS No: 101363-10-4 Catalog No: AG0004AN MDL No:MFCD00865073

Product Description

Catalog Number:
AG0004AN
Chemical Name:
7H-Pyrido[1,2,3-de]-1,4-benzothiazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-10-(4-methyl-1-piperazinyl)-7-oxo-
CAS Number:
101363-10-4
Molecular Formula:
C17H18FN3O3S
Molecular Weight:
363.4065
MDL Number:
MFCD00865073
IUPAC Name:
7-fluoro-6-(4-methylpiperazin-1-yl)-10-oxo-4-thia-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid
InChI:
InChI=1S/C17H18FN3O3S/c1-19-2-4-20(5-3-19)14-12(18)8-10-13-16(14)25-7-6-21(13)9-11(15(10)22)17(23)24/h8-9H,2-7H2,1H3,(H,23,24)
InChI Key:
NJCJBUHJQLFDSW-UHFFFAOYSA-N
SMILES:
CN1CCN(CC1)c1c(F)cc2c3c1SCCn3cc(c2=O)C(=O)O
UNII:
Y521XM2900
NSC Number:
759835

Properties

Complexity:
608  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
363.105g/mol
Formal Charge:
0
Heavy Atom Count:
25  
Hydrogen Bond Acceptor Count:
8  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
363.407g/mol
Monoisotopic Mass:
363.105g/mol
Rotatable Bond Count:
2  
Topological Polar Surface Area:
89.4A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
-0.3  

Literature

Title Journal
Quadruple therapy with medications containing either rufloxacin or furazolidone as a rescue regimen in the treatment of Helicobacter pylori-infected dyspepsia patients: a randomized pilot study. Helicobacter 20110801
Effects of bio-compatible metal ions on rufloxacin photochemistry, photophysics and photosensitization: copper(II). Journal of photochemistry and photobiology. B, Biology 20101202
Photosensitization induced by the antibacterial fluoroquinolone Rufloxacin leads to mutagenesis in yeast. Mutation research 20101013
Quinolones for uncomplicated acute cystitis in women. The Cochrane database of systematic reviews 20060719
Rufloxacin induced photosensitization in bio-models of increasing complexity. Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology 20050301
Photochemical properties of ofloxacin involved in oxidative DNA damage: a comparison with rufloxacin. Chemical research in toxicology 20030401
Type II guanine oxidation photoinduced by the antibacterial fluoroquinolone Rufloxacin in isolated DNA and in 2'-deoxyguanosine. Chemical research in toxicology 20020901
Photoinduced N-demethylation of rufloxacin and its methyl ester under aerobic conditions. Photochemistry and photobiology 20020901
Optimization and validation of a CZE method for rufloxacin hydrochloride determination in coated tablets. Journal of pharmaceutical and biomedical analysis 20020615
Daily norfloxacin is more effective than weekly rufloxacin in prevention of spontaneous bacterial peritonitis recurrence. Digestive diseases and sciences 20020601
6-Aminoquinolones as new potential anti-HIV agents. Journal of medicinal chemistry 20001005
Prediction of quinolone activity against Mycobacterium avium by molecular topology and virtual computational screening. Antimicrobial agents and chemotherapy 20001001
Anti-toxoplasma activities of 24 quinolones and fluoroquinolones in vitro: prediction of activity by molecular topology and virtual computational techniques. Antimicrobial agents and chemotherapy 20001001
Effects of some quinolones on imipenem-induced seizures in DBA/2 mice. General pharmacology 19940301
The in-vitro activity of two new quinolones: rufloxacin and MF 961. The Journal of antimicrobial chemotherapy 19920601

Related Products

© 2019 Angene International Limited. All rights Reserved.